2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid

C36H34N4O3 — CID 155525343

IUPAC2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
SMILESCCc1nc2c(C)cc(C(=O)NCCCc3ccccc3)cc2n1Cc1cccc2c1ccn2-c1ccccc1C(=O)O
InChIInChI=1S/C36H34N4O3/c1-3-33-38-34-24(2)21-27(35(41)37-19-10-13-25-11-5-4-6-12-25)22-32(34)40(33)23-26-14-9-17-30-28(26)18-20-39(30)31-16-8-7-15-29(31)36(42)43/h4-9,11-12,14-18,20-22H,3,10,13,19,23H2,1-2H3,(H,37,41)(H,42,43)
InChIKeyFMPBVZXHMHKSDB-UHFFFAOYSA-N
MW570.69 g/mol
LogP6.96
Rot. Bonds10

About 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid

2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid (PubChem CID 155525343) has the molecular formula C36H34N4O3 and a molecular weight of 570.69 g/mol. Its IUPAC name is 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid.

Molecular Properties

Compound Name2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
PubChem CID155525343
Molecular FormulaC36H34N4O3
Molecular Weight570.69 g/mol
Exact Mass570.26
IUPAC Name2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid
SMILESCCc1nc2c(C)cc(C(=O)NCCCc3ccccc3)cc2n1Cc1cccc2c1ccn2-c1ccccc1C(=O)O
InChIInChI=1S/C36H34N4O3/c1-3-33-38-34-24(2)21-27(35(41)37-19-10-13-25-11-5-4-6-12-25)22-32(34)40(33)23-26-14-9-17-30-28(26)18-20-39(30)31-16-8-7-15-29(31)36(42)43/h4-9,11-12,14-18,20-22H,3,10,13,19,23H2,1-2H3,(H,37,41)(H,42,43)
InChIKeyFMPBVZXHMHKSDB-UHFFFAOYSA-N
XLogP6.96
TPSA89.15 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds10
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500570.69
LogP ≤ 56.96
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid?
The IUPAC name of 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid (CID 155525343) is 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid.
What is the SMILES notation for 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid?
The canonical SMILES for 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid is CCc1nc2c(C)cc(C(=O)NCCCc3ccccc3)cc2n1Cc1cccc2c1ccn2-c1ccccc1C(=O)O.
What is the InChIKey of 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid?
The InChIKey is FMPBVZXHMHKSDB-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H34N4O3/c1-3-33-38-34-24(2)21-27(35(41)37-19-10-13-25-11-5-4-6-12-25)22-32(34)40(33)23-26-14-9-17-30-28(26)18-20-39(30)31-16-8-7-15-29(31)36(42)43/h4-9,11-12,14-18,20-22H,3,10,13,19,23H2,1-2H3,(H,37,41)(H,42,43).
What are the key properties of 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid?
2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid has a molecular weight of 570.69 g/mol, XLogP of 6.96, 10 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[2-ethyl-4-methyl-6-(3-phenylpropylcarbamoyl)benzimidazol-1-yl]methyl]indol-1-yl]benzoic acid is sourced from PubChem (CID 155525343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).